Company

Technology

Discover scalable, instrument-free single cell sequencing technology from Parse Bioscience

Technology Overview


Resources

Explore our collection of resources to learn more about technology and its applications from leading researchers

Resources Overview

Company

Providing researchers single cell sequencing with unprecedented scale and ease

About Parse

Parse news at scale

The latest news stories and press releases from Parse Biosciences.

July 11, 2024

Parse Biosciences Launches Certified Service Provider Program

Eurofins Clinical Enterprise, LLC and SeqMatic first providers to join program, expanding access to Parse’s…

Read more
June 25, 2024

Parse Biosciences Announces Partnership with Gencell Pharma to Extend its Reach in South America

Agreement broadens access to single cell research in the region

Read more
May 30, 2024

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

New cloud platform facilitates streamlined, end-to-end analysis of single cell data

Read more
May 02, 2024

Parse Biosciences Launches Single Cell Immune Profiling Products

New single cell BCR and TCR profiling products enable immune profiling at unprecedented scale SEATTLE…

Read more
April 24, 2024

Parse Biosciences Launches Laboratory Automation Provider Program, Collaborates with Hamilton, Opentrons Labworks, SPT Labtech

Program will support faster insights for large-scale studies and drug development SEATTLE – April 24,…

Read more
February 21, 2024

Parse Biosciences Launches Evercode Whole Transcriptome Version 3, Boosting Usability and Performance

Transformative, instrument-free solution for single cell RNA sequencing updated with improved sensitivity, faster workflow SEATTLE —…

Read more
February 06, 2024

Parse Biosciences Partners with INTEGRA Biosciences for Automated Single Cell Workflows

SEATTLE – February 6, 2024 – Parse Biosciences, a leading provider of accessible and scalable…

Read more
January 16, 2024

Parse Biosciences Acquires Biomage

Analysis platform enables powerful, accessible single cell data exploration SEATTLE — January 16, 2024 — Parse…

Read more
December 14, 2023

Parse Biosciences Closes $50 Million of Financing to Fuel Continued Worldwide Growth

Funding will drive expansion of company’s product portfolio and commercial reach. SEATTLE — December 14,…

Read more
November 07, 2023

Parse Biosciences Extends Global Reach with India-based Spinco Biotech Partnership

SEATTLE — November 7, 2023 — Parse Biosciences, a leading provider of accessible and scalable single…

Read more